Are ruxolitinib cream and ruxolitinib the same medicine?

Ruxolitinib cream and ruxolitinib are not the same medicine. Although their core ingredients are similar, there are significant differences in drug forms, uses, administration methods, and treatment indications.

Ruxolitinib cream and ruxolitinib both contain ruxolitinib (Ruxolitinib), a small molecule Janus stimulant Enzyme (JAK) inhibitors, especially inhibitors of JAK1 and JAK2. However, ruxolitinib cream is the topical formulation of ruxolitinib that comes in cream form and is designed for topical use. Ruxolitinib usually refers to its oral formulation.

Ruxolitinib cream is mainly used for topical treatment of autoimmune inflammatory skin diseases, such as vitiligo and atopic dermatitis (AD). According to clinical trials, ruxolitinib cream has shown significant efficacy in treating this condition. Ruxolitinib oral preparation is mainly used to treat myelofibrosis, a serious disease that affects the hematopoietic function of the bone marrow. In addition, it is also being used exploratoryly to treat other inflammatory diseases.

Ruxolitinib cream is a topical drug that is applied directly to the affected area. This method reduces systemic side effects and improves the safety and local effect of the drug. As an oral drug, ruxolitinib needs to be absorbed through the digestive system and acts throughout the body, so it may cause some systemic side effects.

The efficacy of ruxolitinib cream in treating skin diseases such as atopic dermatitis and vitiligo has been approved by FDA and has been verified in clinical trials. For example, when treating vitiligo, it stimulates melanocyte regeneration and pigmentation, thereby helping to restore skin color.

Ruxolitinib has also achieved significant efficacy in the treatment of myelofibrosis and is widely recognized as an effective drug for the treatment of this disease.